Amy C. Doty
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Ophthalmology top 10%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
Papers in
-
- Advanced Drug Delivery Systems 4
- Drug Solubulity and Delivery Systems 3
-
- RNA Interference and Gene Delivery 2
- Protein purification and stability 1
- Co-authors
- Steven P. Schwendeman (3 shared papers)Stephanie Choi (4 shared papers)Rose Ackermann (3 shared papers)Yan Wang (3 shared papers)Karl Olsen (3 shared papers)Keiji Hirota (3 shared papers)Wen Qu (3 shared papers)Steven P. Schwendeman (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Biomaterials (1 paper)Journal of Pharmaceutical Sciences (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Chemistry and Physics of Lipids (1 paper)
- Partner nations
- United States
In The Last Decade
Amy C. Doty
8 papers receiving 326 citations
Peers
Comparison fields: 5 of 77
- Pharmaceutical Science 179
- Ophthalmology 56
- Molecular Medicine 27
- Biomaterials 71
- Public Health, Environmental and Occupational Health 46
Countries citing papers authored by Amy C. Doty
This map shows the geographic impact of Amy C. Doty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Doty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Doty more than expected).
Fields of papers citing papers by Amy C. Doty
This network shows the impact of papers produced by Amy C. Doty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Doty. The network helps show where Amy C. Doty may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy C. Doty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 77 | |
| 2 | 2016 | 74 | |
| 3 | 2016 | 69 | |
| 4 | 2016 | 40 | |
| 5 | 2011 | 29 | |
| 6 | 2016 | 25 | |
| 7 | 2020 | 10 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 1 |
About Amy C. Doty
Amy C. Doty is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Cellular and Molecular Neuroscience and Biological Psychiatry, having authored 9 papers that have together received 331 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Drug Solubulity and Delivery Systems (3 papers), Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (2 papers), Ocular Surface and Contact Lens (1 paper), Glaucoma and retinal disorders (1 paper), Protein purification and stability (1 paper) and Corneal surgery and disorders (1 paper). The work is most often cited by research in Pharmaceutical Science (179 citations), Ophthalmology (56 citations), Molecular Medicine (27 citations), Biomaterials (71 citations) and Public Health, Environmental and Occupational Health (46 citations). Amy C. Doty has collaborated with scholars based in United States. Frequent co-authors include Steven P. Schwendeman, Stephanie Choi, Rose Ackermann, Yan Wang, Karl Olsen, Keiji Hirota, Wen Qu, Steven P. Schwendeman, Bryce Chiang and Hans E. Grossniklaus. Their work appears in journals such as Journal of Controlled Release, Biomaterials, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics and Chemistry and Physics of Lipids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.